Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL539151 | 0.83 | — | — | |
| SCHEMBL27259953 | 0.83 | — | — | |
| SCHEMBL7537168 | 0.82 | MAOA (0.38) | ALDH1A1TAAR1HSD17B10TDP1SMN1; SMN2 | |
| Fluoride SCHEMBL7642269 | 0.81 | — | — | |
| Methane SCHEMBL8381074 | 0.81 | — | — | |
| Bromide SCHEMBL7888005 | 0.81 | — | — | |
| Bromide SCHEMBL8712554 | 0.81 | — | — | |
| Iodide SCHEMBL8155731 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL138985 | 0.81 | — | — | |
| SCHEMBL4576530 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332551-B2 | Partially fluorinated naphthyl-based borates | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-7077977-B2 | Bulky borate activations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-07-18 | — | — | US | disclosed |
| US-6909008-B2 | Cocatalyst compositions | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-06-21 | — | — | US | disclosed |
| US-20050049436-A1 | Partially fluorinated naphthyl-based borates | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-03-03 | — | — | US | disclosed |
| US-20040254065-A1 | Bulky borate activations | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-16 | — | — | US | disclosed |
| US-20040199021-A1 | DICOPS CONTAINING ACETYLENIC SUBSTITUENTS | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-10-07 | — | — | US | disclosed |
| EP-1463738-A1 | PARTIALLY FLUORINATED NAPHTHYL-BASED BORATES | Exxonmobil Chemical Patents Inc. (US) | 2004-10-06 | — | — | EP | disclosed |
| EP-1461152-A1 | BULKY BORATE ACTIVATORS | ExxonMobil Chemical Patents Inc. (US) | 2004-09-29 | — | — | EP | disclosed |
| US-20040152591-A1 | Polymerized metallocene catalyst composition | EXXONMOBIL CHEMICAL PATENTS, INC. | 2004-08-05 | — | — | US | disclosed |
| EP-0927201-B1 | CATALYST SYSTEM FOR (CO)POLYMERIZATION OF OLEFINS AND PROCESS FOR THE PREPARATION OF OLEFIN (CO)POLYMERS USING THE CATALYST SYSTEM | HYUNDAI PETROCHEMICAL CO LTD (KR) | 2004-04-14 | — | — | EP | disclosed |
| EP-0705848-A2 | Compositions useful for olefin polymerization and processes therefor and therewith | PHILLIPS PETROLEUM COMPANY (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0669346-A1 | Solid catalyst components for olefin polymerization and use thereof | NIPPON OIL CO. LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
| EP-0434469-B1 | Hydrogenation catalyst composition and process for hydrogenating olefinically unsaturated polymer using the same | JAPAN SYNTHETIC RUBBER CO LTD (JP) | 1995-02-22 | — | — | EP | disclosed |
| US-5270274-A | Catalyst composition for hydrogenating olefinically unsaturated polymers | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1993-12-14 | — | — | US | disclosed |
| EP-0544304-A1 | Catalyst composition for hydrogenating olefinically unsaturated polymers | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1993-06-02 | — | — | EP | disclosed |
| EP-0303519-B1 | POLYMERIZATION OF ETHYLENE | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1993-03-31 | — | — | EP | disclosed |
| US-5169905-A | Using a bis(cyclopentadienyl)transition metal compound and an alkali aluminum organic complex as catalyst | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1992-12-08 | — | — | US | disclosed |
| EP-0434469-A2 | Hydrogenation catalyst composition and process for hydrogenating olefinically unsaturated polymer using the same | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-06-26 | — | — | EP | disclosed |
| US-4931517-A | Polymerization of ethylene | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1990-06-05 | — | — | US | disclosed |
| EP-0303519-A1 | Polymerization of ethylene | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1989-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040199021-A1 | DICOPS CONTAINING ACETYLENIC SUBSTITUENTS | AADAC, NAA15, ALG8 | ALDH1A1 1329/4885SLC22A2 3775/4885SLC22A1 3827/4885 |
| US-20050049436-A1 | Partially fluorinated naphthyl-based borates | NBAS, TNK1, POF1B | ALDH1A1 4528/4885SLC22A2 2936/4885SLC22A1 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.